1. Home
  2. Analysis
  3. Erythromycin
  4. Status-epilepticus

Erythromycin and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Erythromycin (erythromycin), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Phenytoin, and have Pneumonia mycoplasmal.

The phase IV clinical study analyzes which people have Status epilepticus when taking Erythromycin. It is created by eHealthMe based on reports of 12,069 people who have side effects when taking Erythromycin from the FDA, and is updated regularly.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 663 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

12,069 people reported to have side effects when taking Erythromycin.
Among them, 41 people (0.34%) have Status epilepticus.

Could Erythromycin cause Status epilepticus?

Among these 41 people:

How long have people been on Erythromycin when they have Status epilepticus? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Status epilepticus when taking Erythromycin? *

  • female: 17.95 %
  • male: 82.05 %

What is the age of people who have Status epilepticus when taking Erythromycin? *

  • 0-1: 2.7 %
  • 2-9: 83.78 %
  • 10-19: 0.0 %
  • 20-29: 5.41 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 5.41 %
  • 60+: 2.7 %

What are other drugs people take besides Erythromycin? *

  1. Phenytoin: 28 people, 68.29%
  2. Valproate Sodium: 25 people, 60.98%
  3. Lamotrigine: 24 people, 58.54%
  4. Cefotaxime: 23 people, 56.10%
  5. Clobazam: 23 people, 56.10%
  6. Gentamicin: 21 people, 51.22%
  7. Piperacillin: 18 people, 43.90%
  8. Clonazepam: 10 people, 24.39%
  9. Diazepam: 10 people, 24.39%
  10. Cefotaxime Sodium: 7 people, 17.07%

What are other side effects people have besides Status epilepticus? *

  1. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 26 people, 63.41%
  2. Speech Impairment (Adult) (inability to speak (adult)): 25 people, 60.98%
  3. Akinesia (loss of control of voluntary muscle movements): 22 people, 53.66%
  4. Hypotonia (low muscle tone): 22 people, 53.66%
  5. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 22 people, 53.66%
  6. Learning Disorder (the brain's disability to receive, process, store, respond to and communicate information): 19 people, 46.34%
  7. Movement - Uncontrolled Or Slow: 19 people, 46.34%
  8. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 18 people, 43.90%
  9. Cerebral Atrophy (decrement in size of brain): 13 people, 31.71%
  10. Fever: 13 people, 31.71%

What are the existing conditions these people have? *

  1. Pneumonia Mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection): 18 people, 43.90%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 14 people, 34.15%
  3. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 26.83%
  4. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 2 people, 4.88%
  5. Upper Respiratory Tract Inflammation: 1 person, 2.44%
  6. Nasopharyngitis (inflammation of the nasopharynx): 1 person, 2.44%
  7. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Erythromycin and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erythromycin:

Status epilepticus treatments and more:

How severe was Status epilepticus and when was it recovered:

Expand to all the drugs that have ingredients of erythromycin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Browse all the conditions that are associated with Status epilepticus:

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin (the active ingredients of Erythromycin) and Erythromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.